Maverick Capital
Today we're very pleased to announce the first issue of Hedge Fund Wisdom, a brand new quarterly newsletter by Market Folly in collaboration with professional hedge fund analysts/investors. Want to know what top managers have…Read
Just a reminder that this is your last chance to benefit from substantial savings for the Value Investing Congress. The event takes place on October 12th 13th in New York City. Market Folly readers can save $1,700 with…Read
The IPO market is setting up for continued investor interest in the biotech sector. Two high profile genomics companies, Complete Genomics (GNOM) and Pacific Biosciences (PACB), have filed S-1 Registration Statements with plans…Read
Pacific Biosciences, a Menlo Park, Calif.-based DNA gene sequencing company, has filed for a $200 million IPO. It plans to trade on the Nasdaq under ticker symbol PACB, with J.P. Morgan and Morgan Stanley serving as co-lead…Read
If you want to receive stock picks and investment ideas from the very hedge fund managers we cover on this site on a daily basis, then this is the event for you: The Value Investing Congress. We've secured a special discount…Read
Roberto Mignone's hedge fund Bridger Management filed a 13G with the SEC after market close today regarding shares of XenoPort (XNPT). Due to portfolio activity on July 7th, Bridger has disclosed a 6.6% ownership stake in…Read
Roberto Mignone's hedge fund Bridger Management filed a 13G with the SEC after market close today regarding shares of XenoPort (XNPT). Due to portfolio activity on July 7th, Bridger has disclosed a 6.6% ownership stake in XNPT…Read
Pacific Biosciences, a Menlo Park, Calif.-based DNA gene sequencing company, has raised $59 million in new Series F funding. This brings the round total to $109 million, including a previously-announced $50 million infusion…Read
Raymond James' Chief Investment Strategist Jeff Saut has penned his weekly market commentary and in it he examins the possibility of the dreaded double-dip recession. Many economists argue that the recession ended around this…Read
Just wanted to remind everyone that the over 40% discount to the Value Investing Congress we've secured for our readers expires tomorrow (June 30th!). Click here to receive the discount with code N10MF1. Take advantage of…Read
Join us for the 6th Annual New York Value Investing Congress, taking place October 12 & 13, 2010 in New York City, to learn and profit from some of the world’s most extraordinary money managers. You’ll (L)EARN…Read
John Burbank's hedge fund firm Passport Capital is out with its May performance update and first quarter investor letter. Per the documents, we see that Passport now manages $3 billion and its Global Strategy Fund was up…Read
June has been heating up for life sciences companies replenishing their coffers. Only three weeks after announcing positive mid-stage data on its endometriosis-related pain therapeutic elagolix, Neurocrine Biosciences (NBIX)…Read
The upcoming Value Investing Congress has an absolutely fantastic group of speakers lined up. We're pleased to announce that both Maverick Capital's Lee Ainslie and Hayman Capital's Kyle Bass have committed to speak at the…Read